Skip to content

Analysis, Evaluation and Improvement of Medical Quality for Reperfusion Treatment of Acute Ischemic Stroke Patients in Shanxi Province

Analysis, evaluation and improvement of integrated medical quality for stroke in Shanxi Province

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075953
Enrollment
Unknown
Registered
2023-09-20
Start date
2023-10-09
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Interventions

Case series:N/A

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Acute ischemic stroke patients with onset time = 4.5 hours; (2) Age = 18 years old; (3) Patients undergoing intravenous thrombolysis and/or intravascular treatment.

Exclusion criteria

Exclusion criteria: (1) Patients with acute ischemic stroke patients whose onset time is more than 4.5 hours; (2) Patients who do not meet the criteria for intravenous thrombolysis and thrombectomy.

Design outcomes

Primary

MeasureTime frame
Intravenous thrombolysis rate or intravascular treatment rate in patients with acute ischemic stroke within 4.5 hours of onset;

Secondary

MeasureTime frame
The proportion of patients with DNT<60 minutes from admission to intravenous thrombolysis;The incidence of symptomatic intracranial hemorrhage after intravenous thrombolysis treatment;The ratio of MRS scores<(0-1) in patients treated with ischemia-reperfusion at 90 days after discharge;Intravenous thrombolysis rate in patients with acute ischemic stroke;Intravascular treatment rate for acute ischemic stroke;Rate of hospitalization to puncture time less than 90 minutes;Rate of less than 1 hour of recanalization time from puncture to blood vessel;Neurological deficit score ratio;Treatment rate of antiplatelet drugs within 48 hours of admission;Ratio of discharged patients treated with statins;Prevention of deep vein thrombosis rate;Evaluation rate of swallowing function;Rate of anticoagulant treatment given to patients with atrial fibrillation upon discharge;The antihypertensive treatment rate of cerebral infarction patients with hypertension at discharge;Treatment rate of hypoglycemic drugs for patients with diabetes at discharg;Rate of antiplatelet therapy administered at discharge;Rehabilitation assessment and implementation rate;

Countries

China

Contacts

Public ContactLi Changxin

The First Hospital of Shanxi Medical University

65121421@qq.com+86 176 3511 7907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026